Hospital
San Antonio Regional Hospital
San Antonio Regional Hospital was paid $44.80M by Medicaid between Jan 2018 and Dec 2024, across 312 billing codes. Its largest line is 0450, Emergency room services — 12% of everything it billed.
33Billing provider infoSAN ANTONIO REGIONAL HOSPITAL
UPLAND, CA 91786
UPLAND, CA 91786
33aNPI1780681189assigned 06/30/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$44.80M
24GClaims1,464,898
24DCodes billed312
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in California
Rank by total paid#71 of 410
Median peer was paid$6.90M
This provider vs. median6.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 195,248 | $4.80M | |
| 2019 | 220,374 | $5.31M | |
| 2020 | 149,974 | $4.01M | |
| 2021 | 188,432 | $5.96M | |
| 2022 | 224,418 | $7.55M | |
| 2023 | 249,839 | $8.51M | |
| 2024incomplete | 236,613 | $8.67M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0450 | Emergency room services | 12% | 109,544 | 95,715 | $5.16M |
| L8699 | Prosthetic implant, not otherwise specified | 10.0% | 1,971 | 1,641 | $4.47M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 8.5% | 65,092 | 58,484 | $3.79M |
| 70450 | Computed tomography, head or brain; without contrast material | 4.8% | 15,006 | 14,532 | $2.17M |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3.1% | 51,208 | 46,329 | $1.40M |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 3.0% | 14,321 | 13,898 | $1.33M |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.9% | 108,170 | 91,872 | $1.28M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.8% | 21,724 | 19,883 | $1.26M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.6% | 6,745 | 6,506 | $1.17M |
| 80053 | Comprehensive metabolic panel | 2.6% | 68,800 | 60,895 | $1.17M |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.7% | 25,371 | 23,105 | $752K |
| 78815 | Positron emission tomography (PET) for limited area imaging | 1.7% | 555 | 551 | $750K |
300 more codes
| Q9965 | Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml | 1.7% | 11,176 | $750K |
| 99070 | 1.5% | 80,179 | $674K | |
| Z7502 | 1.5% | 17,808 | $672K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.5% | 16,971 | $666K |
| 99284 | Emergency room visit (serious) | 1.3% | 5,665 | $600K |
| 99285 | Emergency room visit (most serious) | 1.3% | 4,461 | $585K |
| 84484 | 1.2% | 29,377 | $552K | |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.1% | 9,921 | $488K |
| 72125 | Computed tomography, cervical spine; without contrast material | 1.1% | 2,715 | $487K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 1.1% | 2,754 | $476K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.0% | 34,377 | $466K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 12,412 | $447K |
| 83690 | <1% | 38,063 | $435K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 5,891 | $417K |
| G0378 | Hospital observation service, per hour | <1% | 4,270 | $402K |
| 71045 | Radiologic examination, chest; single view | <1% | 38,153 | $393K |
| 99499 | <1% | 6,596 | $372K | |
| 0762 | <1% | 4,401 | $367K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 4,814 | $348K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 1,906 | $341K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 6,038 | $328K |
| 84703 | <1% | 21,809 | $284K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 16,027 | $278K |
| 99221 | <1% | 1,701 | $272K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 676 | $259K |
| 93971 | <1% | 3,078 | $251K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 4,430 | $226K |
| 84702 | <1% | 10,554 | $224K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 622 | $219K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 1,213 | $216K |
| 81003 | <1% | 60,416 | $215K | |
| 76830 | Ultrasound, transvaginal | <1% | 3,207 | $189K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 3,838 | $177K |
| 93458 | <1% | 198 | $165K | |
| 71250 | <1% | 1,218 | $158K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 2,607 | $153K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 6,144 | $152K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 2,725 | $149K |
| 76801 | <1% | 2,747 | $147K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 10,500 | $139K |
| 83880 | <1% | 6,436 | $137K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 5,822 | $132K |
| J3490 | Unclassified drugs | <1% | 33,943 | $129K |
| 70486 | <1% | 726 | $124K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 2,051 | $120K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 2,052 | $119K |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | <1% | 513 | $112K |
| P9016 | Red blood cells, leukocytes reduced, each unit | <1% | 543 | $109K |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 1,810 | $109K |
| 73130 | <1% | 4,375 | $104K | |
| 82948 | <1% | 13,871 | $103K | |
| 76857 | <1% | 2,847 | $102K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 10,421 | $96K |
| 73630 | <1% | 4,302 | $95K | |
| 99152 | <1% | 2,145 | $95K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 1,610 | $93K |
| 73610 | <1% | 3,626 | $90K | |
| 73564 | <1% | 3,754 | $90K | |
| 93970 | <1% | 714 | $87K | |
| 83605 | <1% | 5,165 | $86K | |
| 87040 | <1% | 3,785 | $83K | |
| 73030 | <1% | 3,732 | $83K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 3,017 | $79K |
| 90715 | <1% | 2,728 | $79K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 1,193 | $77K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 4,983 | $72K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 1,166 | $70K |
| 85730 | <1% | 8,512 | $67K | |
| 70496 | <1% | 368 | $66K | |
| 0710 | <1% | 2,639 | $64K | |
| 72100 | <1% | 2,473 | $63K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 1,692 | $58K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 980 | $58K |
| 36415 | Collection of venous blood by venipuncture | <1% | 17,762 | $56K |
| 73110 | <1% | 2,397 | $56K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 4,585 | $54K |
| 87186 | <1% | 4,178 | $54K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 11,532 | $54K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 84 | $50K |
| 84439 | <1% | 3,944 | $49K | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 14,730 | $48K |
| 86923 | <1% | 464 | $48K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 933 | $47K |
| 88307 | <1% | 1,089 | $47K | |
| 83735 | <1% | 5,136 | $46K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 548 | $46K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 10,799 | $45K |
| 85610 | <1% | 9,199 | $45K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 12,333 | $45K |
| 87641 | <1% | 2,192 | $45K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 1,086 | $45K |
| C9290 | Injection, bupivacaine liposome, 1 mg | <1% | 147 | $43K |
| 86901 | <1% | 6,422 | $43K | |
| 76770 | <1% | 958 | $43K | |
| 84145 | <1% | 2,365 | $42K | |
| 76870 | <1% | 758 | $41K | |
| 97750 | <1% | 751 | $41K | |
| 85378 | <1% | 3,493 | $41K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 703 | $41K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 6,767 | $39K |
| 80061 | Lipid panel | <1% | 3,882 | $38K |
| 99199 | Unlisted special service, procedure or report | <1% | 845 | $38K |
| 73080 | <1% | 1,539 | $38K | |
| 86850 | <1% | 3,218 | $38K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,119 | $36K |
| 73502 | <1% | 1,624 | $36K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 22,061 | $36K |
| 70498 | <1% | 362 | $34K | |
| 80076 | <1% | 2,954 | $33K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 2,274 | $33K |
| 87077 | <1% | 4,562 | $32K | |
| 59025 | Fetal non-stress test | <1% | 1,330 | $31K |
| Z7506 | <1% | 211 | $31K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 18,049 | $31K |
| 88342 | <1% | 1,003 | $30K | |
| 86900 | <1% | 6,392 | $29K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,851 | $27K |
| 72040 | <1% | 1,078 | $26K | |
| 93798 | <1% | 1,531 | $26K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,636 | $26K |
| 93356 | <1% | 923 | $26K | |
| 72131 | <1% | 163 | $25K | |
| 99218 | <1% | 157 | $24K | |
| 0250 | <1% | 5,786 | $24K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 137 | $24K |
| 73090 | <1% | 1,184 | $23K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 8,004 | $22K |
| 86140 | <1% | 2,744 | $21K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 9,154 | $21K |
| J1815 | Injection, insulin, per 5 units | <1% | 3,548 | $21K |
| 73590 | <1% | 1,129 | $21K | |
| 12001 | <1% | 878 | $20K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 592 | $20K |
| 74018 | <1% | 944 | $20K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 6,222 | $18K |
| 76937 | <1% | 1,209 | $18K | |
| J0694 | Injection, cefoxitin sodium, 1 gm | <1% | 1,768 | $17K |
| 99153 | Mod sedat endo service >5yrs | <1% | 1,308 | $16K |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 123 | $15K |
| 29125 | <1% | 902 | $14K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 827 | $14K |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 4,019 | $14K |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | <1% | 648 | $14K |
| 97161 | <1% | 927 | $14K | |
| 76000 | <1% | 148 | $13K | |
| 49083 | <1% | 231 | $13K | |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 92 | $12K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 860 | $12K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 2,914 | $12K |
| 82947 | <1% | 1,498 | $11K | |
| 0272 | <1% | 633 | $11K | |
| 0270 | <1% | 4,167 | $11K | |
| 87210 | <1% | 1,552 | $11K | |
| 82550 | <1% | 1,081 | $11K | |
| Z7610 | <1% | 2,329 | $11K | |
| Z7512 | <1% | 398 | $10K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 1,735 | $10K |
| 12011 | <1% | 467 | $10K | |
| 85651 | <1% | 2,125 | $9K | |
| 10060 | <1% | 459 | $9K | |
| 82140 | <1% | 568 | $9K | |
| 76641 | <1% | 157 | $9K | |
| 88304 | <1% | 762 | $8K | |
| 99217 | <1% | 205 | $8K | |
| L1830 | Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf | <1% | 100 | $8K |
| 82607 | <1% | 527 | $8K | |
| 72170 | <1% | 483 | $8K | |
| 36561 | <1% | 41 | $8K | |
| 87807 | <1% | 899 | $8K | |
| 73562 | <1% | 426 | $8K | |
| 87081 | <1% | 744 | $7K | |
| 84100 | <1% | 1,645 | $7K | |
| 97116 | <1% | 1,162 | $7K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 9,162 | $7K |
| 82728 | <1% | 449 | $7K | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 4,471 | $7K |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | <1% | 521 | $6K |
| 58571 | <1% | 13 | $6K | |
| 77001 | <1% | 124 | $6K | |
| 75574 | <1% | 28 | $6K | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 4,683 | $6K |
| J0134 | Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg | <1% | 946 | $6K |
| 96376 | <1% | 823 | $6K | |
| 93017 | <1% | 128 | $6K | |
| 67311 | <1% | 56 | $6K | |
| 82009 | <1% | 782 | $5K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 12 | $5K |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 1,702 | $5K |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | <1% | 1,042 | $5K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 4,291 | $5K |
| 0300 | <1% | 317 | $5K | |
| 96367 | <1% | 140 | $5K | |
| 0001A | <1% | 112 | $4K | |
| 87070 | <1% | 296 | $4K | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 729 | $4K |
| 82746 | <1% | 253 | $4K | |
| 74174 | <1% | 14 | $4K | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 162 | $4K |
| 73560 | <1% | 283 | $4K | |
| A9270 | Non-covered item or service | <1% | 9,386 | $4K |
| 0003A | <1% | 98 | $4K | |
| 77412 | <1% | 140 | $4K | |
| 0002A | <1% | 95 | $4K | |
| 85027 | <1% | 408 | $4K | |
| 29515 | <1% | 327 | $3K | |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 943 | $3K |
| J1953 | Injection, levetiracetam, 10 mg | <1% | 196 | $3K |
| 99224 | <1% | 52 | $3K | |
| 83540 | <1% | 403 | $3K | |
| 73060 | <1% | 162 | $3K | |
| 83550 | <1% | 288 | $3K | |
| Z9725 | <1% | 86 | $3K | |
| A0429 | Emergency ambulance ride, basic life support | <1% | 97 | $2K |
| 73552 | <1% | 130 | $2K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 102 | $2K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 29 | $2K |
| 0160 | <1% | 112 | $2K | |
| 87147 | <1% | 188 | $2K | |
| 0013A | <1% | 52 | $2K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 669 | $2K |
| 12002 | <1% | 113 | $2K | |
| J2704 | Injection, propofol, 10 mg | <1% | 813 | $2K |
| 82570 | <1% | 425 | $2K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 871 | $2K |
| 74019 | <1% | 87 | $2K | |
| J0360 | Injection, hydralazine hcl, up to 20 mg | <1% | 408 | $1K |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | <1% | 342 | $1K |
| 87493 | <1% | 57 | $1K | |
| 82803 | <1% | 49 | $1K | |
| 99225 | <1% | 25 | $1K | |
| 88313 | <1% | 39 | $1K | |
| 71010 | <1% | 89 | $1K | |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 804 | $1K |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 579 | $1K |
| J1940 | Injection, furosemide, up to 20 mg | <1% | 489 | $1K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 15 | $1K |
| 82553 | <1% | 72 | $1K | |
| 88341 | <1% | 12 | $1K | |
| 0370 | <1% | 88 | $1K | |
| 71020 | <1% | 41 | $1K | |
| 94760 | <1% | 323 | $968.21 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 144 | $957.78 |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 29 | $951.88 |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 42 | $922.10 |
| 72072 | <1% | 37 | $863.27 | |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 239 | $857.11 |
| C1769 | Guide wire | <1% | 104 | $796.25 |
| L0140 | Cervical, semi-rigid, adjustable (plastic collar) | <1% | 13 | $773.38 |
| L3908 | Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf | <1% | 12 | $764.67 |
| S0164 | Injection, pantoprazole sodium, 40 mg | <1% | 75 | $756.54 |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 203 | $709.32 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 472 | $706.13 |
| Z7508 | <1% | 12 | $701.64 | |
| L3650 | Shoulder orthosis, figure of eight design abduction restrainer, prefabricated, off-the-shelf | <1% | 14 | $670.93 |
| J1790 | Injection, droperidol, up to 5 mg | <1% | 74 | $586.76 |
| 73100 | <1% | 35 | $552.59 | |
| 94060 | <1% | 12 | $544.50 | |
| 51701 | <1% | 72 | $534.34 | |
| G6040 | Alcohol (ethanol); any specimen except breath | <1% | 42 | $529.20 |
| 0071A | <1% | 13 | $520.00 | |
| J1596 | Injection, glycopyrrolate, 0.1 mg | <1% | 260 | $451.66 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 180 | $419.70 |
| 76536 | <1% | 12 | $412.28 | |
| C1729 | Catheter, drainage | <1% | 23 | $410.82 |
| 86780 | <1% | 29 | $361.42 | |
| 84550 | <1% | 95 | $356.64 | |
| J2310 | Injection, naloxone hydrochloride, per 1 mg | <1% | 37 | $348.01 |
| J1171 | Injection, hydromorphone, 0.1 mg | <1% | 138 | $320.79 |
| 90686 | <1% | 23 | $314.88 | |
| A9540 | Technetium tc-99m macroaggregated albumin, diagnostic, per study dose, up to 10 millicuries | <1% | 12 | $291.06 |
| 93925 | <1% | 13 | $268.37 | |
| 82800 | <1% | 17 | $230.64 | |
| 0258 | <1% | 225 | $229.75 | |
| 97001 | <1% | 16 | $212.63 | |
| 73140 | <1% | 12 | $205.69 | |
| 85018 | <1% | 73 | $195.77 | |
| 84132 | <1% | 37 | $188.10 | |
| 72070 | <1% | 12 | $186.91 | |
| J0456 | Injection, azithromycin, 500 mg | <1% | 18 | $180.72 |
| 80320 | <1% | 246 | $179.61 | |
| 86706 | <1% | 13 | $178.36 | |
| C8929 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography | <1% | 13 | $166.66 |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | <1% | 73 | $153.22 |
| 72110 | <1% | 29 | $127.52 | |
| J3480 | Injection, potassium chloride, per 2 meq | <1% | 57 | $116.90 |
| 87071 | <1% | 17 | $91.42 | |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | <1% | 14 | $91.19 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 150 | $83.78 |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 13 | $75.73 |
| 87205 | <1% | 12 | $68.80 | |
| 29530 | <1% | 12 | $67.83 | |
| 29105 | <1% | 12 | $62.61 | |
| 86592 | <1% | 12 | $53.69 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 12 | $32.32 |
| 99001 | <1% | 77 | $27.23 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 65 | $24.69 |
| 80329 | 0% | 118 | $0.00 | |
| 76376 | 0% | 12 | $0.00 | |
| 0360 | 0% | 43 | $0.00 | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 0% | 40 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHSU, WAH-CHUNG (V.P. FINANCE/CFO)
| Provider | Location | Paid |
|---|---|---|
| The Kingston Hospital | Kingston, NY | $2K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.